REVIEW ONCOLOGY

Emerging concepts in urothelial cancer

D. De Maeseneer, K. Decaestecker, S. Rottey

Immuno-oncology in transitional cell Carcinoma

D. Schrijvers, T. Debacker

Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)

D. Arias, M.A. Flores, Á. Rodríguez, J. de Oliveira, L. Corrales, J.L. Firvida, E.S. Santos, L.E. Raez, C. Rolfo

PRACTICE GUIDELINES

PD-L1 Testing for Non-Small Cell Lung Cancer: Belgian Guidelines

P. Pauwels, M. Remmelink, D. Hoton, J. van Dorpe, K. Dhaene, F. Dome, A. Jouret-Mourin, B. Weynand, N. D’Haene

PHARMACOTHERAPY

Treatment options in patients with early breast cancer and BRCA-mutations or family history of cancer

M-D. Tkint de Roodenbeke, L. Buisserer, M. Piccart-Gebhart

RESEARCH

Blood sampling at home: a pilot project

D. Schrijvers, L. van Asch, A. Van Goethem, E. Heylen, P. de Schouwer, S. van Eeckhout, V. Verheyen

CONGRESS NEWS

Highlights of the 2018 Annual European Neuroendocrine Tumor Society (ENETS) Congress

W. Lybaert, T. Vandamme, G. Boons, T. Rondou, M. Twickler, I. Dero, F. van Fraeyenhove, L. De Backer, D. Van Genechten, M. Peeters

REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier